Author response for "Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial"

Mariaelena Pierobon(George Mason University), Stephen P. Anthony, Mohammad Jahanzeb(Florida Atlantic University), Elisa Baldelli(Abterra Biosciences (United States)), Sanja Avramovic(George Mason University), Julia Wulfkuhle(University of California, San Francisco), Linda Vocila(Translational Genomics Research Institute), Jessica Aldrich, Farrokh Alemi(George Mason University), Ariane Kemkes, Donald W. Northfelt(Mayo Clinic in Arizona), Janusz Wojtusiak(George Mason University), Rosa I. Gallagher(George Mason University), David W. Craig(City of Hope), Nicholas J. Robert(Tufts Medical Center), Amber Conrad(Translational Genomics Research Institute), John D. Carpten(City of Hope), Lance A. Liotta(George Mason University), Shukmei Wong(Translational Genomics Research Institute), David Loesch(Caris Life Sciences (United States)), David Arguello(Caris Life Sciences (United States)), Kimberly A. Hodge(George Mason University), Bryant Dunetz(Side-Out Foundation), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Angela Bellos(George Mason University)
Cited by 0


Related Papers